Ventaira Pharmaceuticals, Inc.

Ventaira Pharmaceuticals, Inc. (Ventaira) is engaged in the development and manufacture of respiratory care products for the healthcare markets. It develops innovative patient therapies and novel pulmonary drug delivery products using its patented technology Mystic. The company operates as a subsidiary of Battelle Memorial Institute. The company is headquartered in Ohio, the US.

The company develops inhaled drugs and drug delivery systems. Its delivery systems includes nebulizers, metered dose inhalers and dry powder inhalers. Its inhaled drugs includes fentanyl for the treatment of breakthrough pain and flucticasone for the treatment of asthma.

Street: 
1801 Watermark Drive
City: 
Columbus
Postcode: 
43215-1037
Federal State : 
United States
WebSite: 
www.ventaira.com
Fax: 
1-614-3402320

Company Index Score

Current Index Score Historical Index Score
  • Ventaira Pharmaceuticals, Inc. currently scores 50 % in the index.
  • Ventaira Pharmaceuticals, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Ventaira Pharmaceuticals, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets